Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury - Wikidata - awgldk - TriplyDB

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury

http://www.wikidata.org/entity/Q36242794

about

Development of prognostic models for patients with traumatic brain injury: a systematic review Systems biology approaches for discovering biomarkers for traumatic brain injury Identification of serum microRNA signatures for diagnosis of mild traumatic brain injury in a closed head injury model.Blood biomarkers for brain injury: What are we measuring?Influence of stochastic gene expression on the cell survival rheostat after traumatic brain injury Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot study Clinical review: neuromonitoring - an update.Potential Blood-based Biomarkers for Concussion.Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy Decreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study.Biomarkers and acute brain injuries: interest and limits Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention.Traumatic alterations in consciousness: traumatic brain injury.αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury.Proteomic identification of proteins differentially expressed in response to resveratrol treatment in middle cerebral artery occlusion stroke model.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.Blood-based diagnostics of traumatic brain injuries.Naloxone for severe traumatic brain injury: a meta-analysis.Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids.Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits Serum levels of neuron-specific ubiquitin carboxyl-terminal esterase-L1 predict brain injury in a canine model of hypothermic circulatory arrest.Multivariate analysis of traumatic brain injury: development of an assessment score.Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study.Early predictors of outcome in infants treated with hypothermia for hypoxic-ischaemic encephalopathy.Voluntary exercise prior to traumatic brain injury alters miRNA expression in the injured mouse cerebral cortex.Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury.Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder.Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.Serum neurogranin measurement as a biomarker of acute traumatic brain injury.Autoimmune Profiling Reveals Peroxiredoxin 6 as a Candidate Traumatic Brain Injury Biomarker Glial Fibrillary Acidic Protein Is Not an Early Marker of Injury in Perinatal Asphyxia and Hypoxic-Ischemic Encephalopathy.Circulating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury.Exploratory study of serum ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein for outcome prognostication after pediatric cardiac arrest.Therapy development for diffuse axonal injury.

P2860

Q26765302-ED0BDDC1-9E6B-4F83-8AF5-A359E4925EAF Q26824124-4CBE003E-2868-4A23-A07F-CB052F7B83BE Q27331576-54E24FC3-C5C0-4AB4-8EB0-BF11CCECB4FC Q28067275-C0715805-5D80-4F6A-B13D-EF53A80B86F9 Q28476525-33C92479-F5A7-4911-A84C-ACB666695D2C Q28535264-7B9B50CC-C9D1-46FB-9408-41AE19262F8B Q30586077-225037C8-DBB6-406A-8F62-2C35BC14C7B8 Q31119100-AB4782E3-2A45-4A35-9CE6-7E0F804D3639 Q33553864-30D7BE4B-FF08-4C25-BE8B-2EEAC0324A0B Q33715071-0CC04A1D-5545-46D2-8D35-5CDBF2359DFE Q33752053-904D1A5B-937A-4357-A177-01A464573407 Q33916315-4C4E9849-9FF8-4F8D-BF5C-CF3117F55928 Q34073157-3506DE35-5DE4-456D-868C-34E88A7CAA3E Q34142573-55E611CF-A378-4DF4-83AD-824C0BA9D70C Q34224506-A6BDE939-F496-42D8-8E93-481A5340B750 Q34456917-39D5AA99-4904-43FB-BCC6-AC339A563CCD Q34619162-94FD2E72-2D75-4966-8825-28A813A1C066 Q34714369-324FB237-EEA1-4573-BCC1-02F42A1A0A34 Q34744164-A036B0D2-811B-4E50-B816-08D37BFB7273 Q35040539-4E990964-1013-475C-81A7-7949D196BA8C Q35142344-7F766F28-F4E8-407B-9FD4-FA3367682921 Q35164692-6DA34B12-3039-4E13-9923-476634A1ADAE Q35224118-6C0195C4-0B72-41BB-BA2B-DFCE717F59A8 Q35229002-B04EDF81-C5BE-436E-A39A-7E42A13DD4E6 Q35558386-6D896134-57F3-4B79-9EDA-58BFBFD7CA24 Q35570888-D22F4400-15C3-47A2-B6F7-DEBE91DECE9F Q35584666-6A4E6E8E-BAA0-4117-B8EA-75DD31D379B6 Q35653473-A09095E4-03F8-4306-8ECC-E88116313738 Q35659358-AAD77ADA-8F5C-4EA9-8EA0-D6DA07AFB64B Q35783757-38D2E824-5574-48F0-B1F6-3819AC332BA4 Q35876807-276A5DF0-2372-44AA-8D56-49F10533DC3F Q35886747-FB87D131-D6B2-47F4-A6A2-2A483F263CAB Q36079583-831615E9-C39D-46B3-8DF3-26214C0723FF Q36131599-931D7AE4-536B-4984-A36A-D260E29E941A Q36155558-36E7D559-9B63-4A01-8BED-FAB6BF1F9F41 Q36294820-1E120B04-D86F-4430-94E2-CD1409BE664B Q36387457-F874A0FF-67B9-4A9B-B2B2-7FB79D036F7F Q36489519-1F26A675-8DB3-40CC-8536-A45B1EC6C85D Q36689419-1C423ACE-85E4-49E6-9CAC-AF2E4EADE0BD Q36768885-EF7BD1CB-FECA-4E3B-B276-CE6B2027194D

P2860

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury

http://www.wikidata.org/entity/Q36242794

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Ubiquitin C-terminal hydrolase ...... severe traumatic brain injury

@ast

Ubiquitin C-terminal hydrolase ...... severe traumatic brain injury

@en

type

label

Ubiquitin C-terminal hydrolase ...... severe traumatic brain injury

@ast

Ubiquitin C-terminal hydrolase ...... severe traumatic brain injury

@en

prefLabel

Ubiquitin C-terminal hydrolase ...... severe traumatic brain injury

@ast

Ubiquitin C-terminal hydrolase ...... severe traumatic brain injury

@en

P1433

Q36242794-5426025F-FC97-4BA8-A861-B41BF2C5B8C2

P1476

Q36242794-0AAB1E56-9594-43F0-B005-891FEA9AD89A

P2093

Q36242794-0024D8E2-48B3-4B1F-A101-CBA50E7BB634

Q36242794-0677E5AC-CB8E-4FC9-BEB0-430DA7987A32

Q36242794-0771B016-69AE-4404-A286-4F5C9402BE18

Q36242794-2337B406-92A7-4E77-837A-0BF7E5C26F2D

Q36242794-2EE2C420-91D2-41A4-B633-DA8142F22DC2

Q36242794-4DAEB5CA-0A1A-4814-B59C-79D91143F0B3

Q36242794-5BAC459B-95CB-46D9-BB13-35C96ED04718

Q36242794-B7F0832B-92D2-423D-BBF6-68709B4DA004

Q36242794-C3C9C736-09D1-41FF-96CE-D1CB74E90287

Q36242794-C75CB303-4BD9-4A3A-ADE5-4AF6BA63E3B3

P2860

Q36242794-0197FDE3-CDC1-43F3-B15F-166F3883EEA0

Q36242794-0475F876-AB8A-4DCE-BDD2-BAAF7DCA2E8E

Q36242794-1685D361-AC0C-4FE2-A126-2EB24431CCF3

Q36242794-1806D5DF-7720-4521-B4AD-B21D09C29EA9

Q36242794-205E02CC-306A-4A32-8E52-AA2C551523D3

Q36242794-2475F991-9D3E-42F5-B4B0-A69E23B9303C

Q36242794-2824C647-DBE1-4FA3-B556-2B9339E3B603

Q36242794-2D9503C0-6A91-47D3-80EF-75C4BCB57C3D

Q36242794-3009F897-231C-4199-8341-C711B5D11C16

Q36242794-365663B7-A521-4A5C-AABC-BE4DFE0C6672

P304

Q36242794-E473A3A8-B025-49AE-B2A4-7D62E64421B5

P31

Q36242794-598DC123-B51D-428A-8562-D9265DFDEB4F

P356

Q36242794-A919D356-B879-418F-9B0D-99F5A77311D1

P407

Q36242794-40A2FE98-065F-4ACB-88D1-1DA81FF5E569

P433

Q36242794-297ED7F5-FEDC-4F94-A9FE-F521DA906A7D

P478

Q36242794-68E92820-9A24-4BAF-9A9E-ED78A0779972

P50

Q36242794-5E109A79-10C8-43DB-BABE-A6A5C888C5C8

Q36242794-7BA8B12F-8C14-4FE0-91E5-BE6C30BE980E

Q36242794-BA11D273-B4AC-41B7-8790-1C6AB37E73E1

Q36242794-CACD476B-5591-4033-A4C4-B067D0EED2A7

P577

Q36242794-A10CF196-91AD-4075-A1AA-5F0471B03872

P698

Q36242794-BFC1E8DB-7660-432F-99EF-9B76927293A4

P921

Q36242794-4FC95AB7-60ED-432E-8118-98747E3711E0

Q36242794-8A41AEB8-092A-4422-A9A5-2B1DDB65731C

P932

Q36242794-ED464D64-3DFC-4124-82CB-4FC24C2CE4CB

P356

CCM.0B013E3181B788AB

P1433

Critical Care Medicine

P1476

Ubiquitin C-terminal hydrolase ...... severe traumatic brain injury

@en

P2093

Andrea Gabrielli

http://www.w3.org/2001/XMLSchema#string

Claudia S Robertson

http://www.w3.org/2001/XMLSchema#string

Gillian Robinson

http://www.w3.org/2001/XMLSchema#string

Jason A Demery

http://www.w3.org/2001/XMLSchema#string

Jose A Pineda

http://www.w3.org/2001/XMLSchema#string

Joseph J Tepas

http://www.w3.org/2001/XMLSchema#string

Linda Papa

http://www.w3.org/2001/XMLSchema#string

Linnet Akinyi

http://www.w3.org/2001/XMLSchema#string

Ming Cheng Liu

http://www.w3.org/2001/XMLSchema#string

Monika W Oli

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical trials in head injury

Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S proteasome

Classification of traumatic brain injury for targeted therapies

Structural basis for the specificity of ubiquitin C-terminal hydrolases

Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type

Pathobiology of ischaemic stroke: an integrated view

Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis

Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons

Assessment of coma and impaired consciousness. A practical scale

Protein aggregation after focal brain ischemia and reperfusion.

P304

138-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CCM.0B013E3181B788AB

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

H. Julia Hannay

Gretchen Brophy

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19726976

http://www.w3.org/2001/XMLSchema#string

P921

traumatic brain injury

P932

3445330

http://www.w3.org/2001/XMLSchema#string